JP2008505075A5 - - Google Patents

Download PDF

Info

Publication number
JP2008505075A5
JP2008505075A5 JP2007519246A JP2007519246A JP2008505075A5 JP 2008505075 A5 JP2008505075 A5 JP 2008505075A5 JP 2007519246 A JP2007519246 A JP 2007519246A JP 2007519246 A JP2007519246 A JP 2007519246A JP 2008505075 A5 JP2008505075 A5 JP 2008505075A5
Authority
JP
Japan
Prior art keywords
tartrate
phenylglycinyl
piperidin
indole
piperazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007519246A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008505075A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/020490 external-priority patent/WO2006011955A1/en
Publication of JP2008505075A publication Critical patent/JP2008505075A/ja
Publication of JP2008505075A5 publication Critical patent/JP2008505075A5/ja
Pending legal-status Critical Current

Links

JP2007519246A 2004-06-30 2005-06-13 1−(インドール−6−カルボニル−d−フェニルグリシニル)−4−(1−メチルピペリジン−4−イル)ピペラジンd−酒石酸塩 Pending JP2008505075A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58359904P 2004-06-30 2004-06-30
PCT/US2005/020490 WO2006011955A1 (en) 2004-06-30 2005-06-13 1 (indole-6-carbonyl-d-phenylglycinyl) -4- (1-methylpiperidin-4-yl) piperazine d-tartrate

Publications (2)

Publication Number Publication Date
JP2008505075A JP2008505075A (ja) 2008-02-21
JP2008505075A5 true JP2008505075A5 (cg-RX-API-DMAC7.html) 2008-08-07

Family

ID=35276192

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007519246A Pending JP2008505075A (ja) 2004-06-30 2005-06-13 1−(インドール−6−カルボニル−d−フェニルグリシニル)−4−(1−メチルピペリジン−4−イル)ピペラジンd−酒石酸塩

Country Status (19)

Country Link
US (1) US20070249623A1 (cg-RX-API-DMAC7.html)
EP (1) EP1763521A1 (cg-RX-API-DMAC7.html)
JP (1) JP2008505075A (cg-RX-API-DMAC7.html)
CN (1) CN1984903A (cg-RX-API-DMAC7.html)
AR (1) AR049659A1 (cg-RX-API-DMAC7.html)
AU (1) AU2005267579A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0512245A (cg-RX-API-DMAC7.html)
CA (1) CA2570634A1 (cg-RX-API-DMAC7.html)
EA (1) EA010307B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP067105A (cg-RX-API-DMAC7.html)
IL (1) IL179903A0 (cg-RX-API-DMAC7.html)
MA (1) MA28842B1 (cg-RX-API-DMAC7.html)
MX (1) MXPA06015112A (cg-RX-API-DMAC7.html)
NO (1) NO20070486L (cg-RX-API-DMAC7.html)
PE (1) PE20060480A1 (cg-RX-API-DMAC7.html)
SV (1) SV2006002156A (cg-RX-API-DMAC7.html)
TW (1) TW200603806A (cg-RX-API-DMAC7.html)
WO (1) WO2006011955A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200610091B (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0616574D0 (en) * 2006-08-21 2006-09-27 Glaxo Group Ltd Compounds
CN107365304A (zh) * 2017-08-01 2017-11-21 齐宜涛 一种治疗心血管疾病的化合物及制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
GB9821058D0 (en) * 1998-09-28 1998-11-18 Univ Cardiff Chemical compound
JP2002539194A (ja) * 1999-03-15 2002-11-19 ノボ ノルディスク アクティーゼルスカブ 新規の(2r,3r,4r)−3,4−ジヒドロキシ−2−ヒドロキシメチルピロリジンの塩
WO2000076971A2 (en) * 1999-06-14 2000-12-21 Eli Lilly And Company Serine protease inhibitors
US6448293B1 (en) * 2000-03-31 2002-09-10 Pfizer Inc. Diphenyl ether compounds useful in therapy
GB0030304D0 (en) * 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0019228D0 (en) * 2000-08-04 2000-09-27 Smithkline Beecham Plc Novel pharmaceutical
GEP20053712B (en) * 2001-05-14 2005-12-26 Pfizer Prod Inc Tartrate Salts of 5,8,14-Triazatetracyclo {10.3.1.0²,11.04,9}-Hexadeca-2(11),3,5,7,9-Pentaene and Pharmaceutical Compositions Thereof
TWI257389B (en) * 2001-06-12 2006-07-01 Lilly Co Eli Pharmaceutical compound

Similar Documents

Publication Publication Date Title
IL189500A (en) 4, 2-Diaminopyrimidines are preserved in position 5, containing pharmaceutical preparations and using them to prepare a drug for the treatment of 3x2p receptor mediated diseases and 2/3 x2p
JP2010513478A5 (cg-RX-API-DMAC7.html)
TWI315203B (en) Process for producing sterile suspensions of slightly soluble basic peptide complexes, sterile suspensions of slightly soluble basic peptide complexes, pharmaceutical formulations containing them, and the use thereof as medicaments
JP2005500357A5 (cg-RX-API-DMAC7.html)
WO2007058602A3 (en) Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia.
WO2007048066A3 (en) Pyrazolo-pyrimidines as casein kinase ii (ck2) modulators
UY29406A1 (es) Forma cristalina gamma de clorhidrato de ivabradina, su procedimiento de preparación y composiciones farmacéuticas que la contienen.
JP2010536849A5 (cg-RX-API-DMAC7.html)
IL167900A (en) Use of betamimetics to prepare a medical preparation for the treatment of chronic obstructive pulmonary disease
JP2008513510A5 (cg-RX-API-DMAC7.html)
JP2012512885A5 (cg-RX-API-DMAC7.html)
TW200738241A (en) Pyridazine derivatives
JP2010535814A5 (cg-RX-API-DMAC7.html)
UA92000C2 (en) 1-benzylindole-2-carboxamide derivatives
ATE495747T1 (de) Kristalline form des ibandronat-natriums und herstellungsverfahren dafür
JP2009536652A5 (cg-RX-API-DMAC7.html)
TW200716628A (en) Novel compounds
TW200722081A (en) New therapeutic combinations for the treatment or prevention of depression
JP2008516004A5 (cg-RX-API-DMAC7.html)
JP2011519873A5 (cg-RX-API-DMAC7.html)
IL187575A (en) Benzofuranyl derivatives ,pharmaceutical formulations comprising the same and use thereof in the preparation of medicaments for the treatment of 5-ht6-receptor related disorders
TW200604196A (en) New quinuclidine derivatives and pharmaceutical compositions comprising them
JP2007119497A5 (cg-RX-API-DMAC7.html)
JP2009532434A5 (cg-RX-API-DMAC7.html)
MY145581A (en) Combination of ferroquine and an artemisinin derivative for the treatment of malaria